1887

Abstract

There is a need for new compounds to effectively treat methicillin-resistant (MRSA) and vancomycin-resistant (VRE). The novel monobiguanide compound 1-(3,4-dichlorobenzyl)-5-octylbiguanide gluconate (OPB-2045G) has potential bactericidal activity. We sought to elucidate the potency of OPB-2045G bactericidal activity against MRSA and VRE compared to those of chlorhexidine digluconate (CHG) and povidone iodine (PVP-I). bactericidal activity was analysed using minimum bactericidal concentration (MBC) as the index. The bactericidal efficacy of OPB-2045G was examined by determining MRSA and VRE contamination of the normal dorsal skin of mice following removal of hair. After a 3 min treatment period, the MBC of OPB-2045G was lower than that of CHG and PVP-I against standard strains and clinical isolates. Additionally, in our mouse model, the bactericidal activity of 1.5 % OPB-2045G (a clinically relevant dose) was higher than that of 0.5 % CHG and equivalent to that of 10 % PVP-I against MRSA. Similarly, the bactericidal activity of OPB-2045G was higher than that of 0.5 % CHG and 10 % PVP-I against VRE. OPB-2045G showed more potent bactericidal activity against MRSA and VRE both and compared to CHG and PVP-I, indicating that OPB-2045G may provide better protection against health care-associated infections caused by these pathogens.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.080861-0
2015-01-01
2019-12-12
Loading full text...

Full text loading...

/deliver/fulltext/jmm/64/1/32.html?itemId=/content/journal/jmm/10.1099/jmm.0.080861-0&mimeType=html&fmt=ahah

References

  1. ASTM ( 2013;). E1174–13: Standard test method for evaluation of the effectiveness of health care personnel handwash formulations. . In Annual Book of ASTM Standards, vol. 11.05. West Conshohocken, PA:: ASTM International;.
    [Google Scholar]
  2. Backman C., Taylor G., Sales A., Marck P. B.. ( 2011;). An integrative review of infection prevention and control programs for multidrug-resistant organisms in acute care hospitals: a socio-ecological perspective. . Am J Infect Control 39:, 368–378. [CrossRef][PubMed]
    [Google Scholar]
  3. Darouiche R. O., Wall M. J. Jr, Itani K. M. F., Otterson M. F., Webb A. L., Carrick M. M., Miller H. J., Awad S. S., Crosby C. T.. & other authors ( 2010;). Chlorhexidine-alcohol versus povidone-iodine for surgical-site antisepsis. . N Engl J Med 362:, 18–26. [CrossRef][PubMed]
    [Google Scholar]
  4. De Angelis G., Cataldo M. A., De Waure C., Venturiello S., La Torre G., Cauda R., Carmeli Y., Tacconelli E.. ( 2014;). Infection control and prevention measures to reduce the spread of vancomycin-resistant enterococci in hospitalized patients: a systematic review and meta-analysis. . J Antimicrob Chemother 69:, 1185–1192. [CrossRef][PubMed]
    [Google Scholar]
  5. Digison M. B.. ( 2007;). A review of anti-septic agents for pre-operative skin preparation. . Plast Surg Nurs 27:, 185–189. [CrossRef][PubMed]
    [Google Scholar]
  6. Garnes A. L., Davidson E., Taylor L. E., Felix A. J., Shidlovsky B. A., Prigot A.. ( 1959;). Clinical evaluation of povidone-iodine aerosol spray in surgical practice. . Am J Surg 97:, 49–53. [CrossRef][PubMed]
    [Google Scholar]
  7. Ito S.. ( 2000;). Drug therapy for breast-feeding women. . N Engl J Med 343:, 118–126. [CrossRef][PubMed]
    [Google Scholar]
  8. Jones R. N.. ( 2001;). Resistance patterns among nosocomial pathogens: trends over the past few years. . Chest 119: (Suppl), 397S–404S. [CrossRef][PubMed]
    [Google Scholar]
  9. Kampf G., Höfer M., Wendt C.. ( 1999;). Efficacy of hand disinfectants against vancomycin-resistant enterococci in vitro. . J Hosp Infect 42:, 143–150. [CrossRef][PubMed]
    [Google Scholar]
  10. Kobayashi H., Tsuzuki M., Hosobuchi K.. ( 1989;). Bactericidal effects of antiseptics and disinfectants against methicillin-resistant Staphylococcus aureus. . Infect Control Hosp Epidemiol 10:, 562–564. [CrossRef][PubMed]
    [Google Scholar]
  11. Kramer A., Wagenvoort H., Ahrén C., Daniels-Haardt I., Hartemann P., Kobayashi H., Kurcz A., Picazo J., Privitera G., Assadian O.. ( 2010;). Epidemiology of MRSA and current strategies in Europe and Japan. . GMS Krankenhhyg Interdiszip 5:, Doc01.[PubMed]
    [Google Scholar]
  12. Magill S. S., Edwards J. R., Bamberg W., Beldavs Z. G., Dumyati G., Kainer M. A., Lynfield R., Maloney M., McAllister-Hollod L.. & other authors ( 2014;). Multistate point-prevalence survey of health care-associated infections. . N Engl J Med 370:, 1198–1208. [CrossRef][PubMed]
    [Google Scholar]
  13. Maillard J. Y., Messager S., Veillon R.. ( 1998;). Antimicrobial efficacy of biocides tested on skin using an ex-vivo test. . J Hosp Infect 40:, 313–323. [CrossRef][PubMed]
    [Google Scholar]
  14. Messager S., Goddard P. A., Dettmar P. W., Maillard J. Y.. ( 2001;). Determination of the antibacterial efficacy of several antiseptics tested on skin by an ‘ex-vivo’ test. . J Med Microbiol 50:, 284–292.[PubMed]
    [Google Scholar]
  15. Morioka I., Takahashi N., Kitajima H..Committee for Infection Prevention and Vaccine Promotion of the Japan Society for Premature and Newborn Medicine ( 2014;). Prevalence of MRSA colonization in Japanese neonatal care unit patients in 2011. . Pediatr Int 56:, 211–214. [CrossRef][PubMed]
    [Google Scholar]
  16. Oishi T., Iwata S., Nonoyama M., Tsuji A., Sunakawa K.. ( 2004;). Double-blind comparative study on the care of the neonatal umbilical cord using 80% ethanol with or without chlorhexidine. . J Hosp Infect 58:, 34–37. [CrossRef][PubMed]
    [Google Scholar]
  17. Paulson D. S.. ( 2003;). Handbook of Topical Antimicrobials: Industrial Applications in Consumer Products and Pharmaceuticals. New York:: Marcel Dekker;.
    [Google Scholar]
  18. Sakuragi T., Yanagisawa K., Dan K.. ( 1995;). Bactericidal activity of skin disinfectants on methicillin-resistant Staphylococcus aureus. . Anesth Analg 81:, 555–558.[PubMed]
    [Google Scholar]
  19. Sauerbrei A., Wutzler P.. ( 2010;). Virucidal efficacy of povidone-iodine-containing disinfectants. . Lett Appl Microbiol 51:, 158–163.[PubMed]
    [Google Scholar]
  20. Silvestri D. L., McEnery-Stonelake M.. ( 2013;). Chlorhexidine: uses and adverse reactions. . Dermatitis 24:, 112–118. [CrossRef][PubMed]
    [Google Scholar]
  21. Simor A. E., Williams V., McGeer A., Raboud J., Larios O., Weiss K., Hirji Z., Laing F., Moore C., Gravel D..Community and Hospital Infection Control Association–Canada ( 2013;). Prevalence of colonization and infection with methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus and of Clostridium difficile infection in Canadian hospitals. . Infect Control Hosp Epidemiol 34:, 687–693. [CrossRef][PubMed]
    [Google Scholar]
  22. Tsubouchi H., Ohguro K., Yasumura K., Ishikawa H., Kikuchi M.. ( 1997;). Synthesis and structure-activity relationships of novel antiseptics. . Bioorg Med Chem Lett 7:, 1721–1724. [CrossRef]
    [Google Scholar]
  23. Zamora J. L., Price M. F., Chuang P., Gentry L. O.. ( 1985;). Inhibition of povidone-iodine’s bactericidal activity by common organic substances: an experimental study. . Surgery 98:, 25–29.[PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.080861-0
Loading
/content/journal/jmm/10.1099/jmm.0.080861-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error